VIrtual Reality in Cognitive Rehabilitation of Processing Speed for Persons With ABI
Virtual Reality in Cognitive Rehabilitation of Processing Speed for Persons With Acquired Brain Injury
1 other identifier
interventional
100
1 country
1
Brief Summary
One hundred participants with acquired brain injury (ABI) will be included in a randomized controlled trial, with one group playing a commercially available VR game and the control group doing activities in their everyday as cognitive training. The trial aims to investigate how VR can affect processing speed in the ABI population, and if these effects can transfer into everyday activities. The training will be performed in the participants homes, with assistance provided by the project group via phone or video conference. The training period will last five weeks. Participant's cognitive functions will be measured with questionnaires and neuropsychological tests at the start of the training period, at the end of training and sixteen weeks after the start of the intervention. In depth experiences with VR as a training method will be gathered through performing focus group interviews with some of the participants from the VR group, in addition to self-reported questionnaires from all the participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2022
CompletedFirst Posted
Study publicly available on registry
July 5, 2022
CompletedStudy Start
First participant enrolled
September 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedNovember 8, 2022
November 1, 2022
1.2 years
May 19, 2022
November 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in processing speed
Connors Continous Performance test 3rd edition, Coefficient of Variation
Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Secondary Outcomes (6)
Change in patient reported executive functioning
Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Transfer effect to everyday activities
Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Change in working memory
Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Change in working memory
Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Change in informant reported executive functioning
Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
- +1 more secondary outcomes
Study Arms (2)
Virtual Reality Group
EXPERIMENTALGroup 1 will play a VR game using an Oculus Quest 2 in a home setting
Active control group
ACTIVE COMPARATORThe control group will be given a pamphlet containing exercises affecting working memory, attention and processing speed to be performed in a home setting
Interventions
Game to be played is a commercially available VR game
Eligibility Criteria
You may qualify if:
- Patients in stable phase after Acquired brain injury, minimum one year after injury
- Physically able to operate VR-technology
- Norwegian or English skills adequate to understand instructions, play the VR-games and to provide valid responses to assessment methods
You may not qualify if:
- Severe aphasia affecting their understanding of instructions
- Apraxia affecting their ability to use VR-equipment
- Visual neglect
- Severe mental illness, substance abuse or co-existing neurological disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sunnaas Rehabilitation Hospitallead
- Oslo Metropolitan Universitycollaborator
- Norwegian University of Science and Technologycollaborator
Study Sites (1)
Sunnaas Rehabilitation Hospital
Nesoddtangen, Akershus, 1453, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marianne Løvstad, PhD
Sunnaas Rehabilitation hopsital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2022
First Posted
July 5, 2022
Study Start
September 15, 2022
Primary Completion
December 1, 2023
Study Completion
December 1, 2024
Last Updated
November 8, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share
Data will be deidentified and will not be made publicly available due to data protection regulations